Standard Biotools (LAB) Price to Sales (2011 - 2026)

Standard Biotools (LAB) has reported Price to Sales for 16 consecutive years, with 15.99 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 24.01% year-over-year to 15.99 in Q2 2026; TTM through Jun 2026 was 3.8, a 26.27% decrease from a year earlier, with the FY2025 full-year figure at 5.8, down 20.16% from the prior year.
• Price to Sales was 15.99 for Q2 2026 at Standard Biotools, down from 16.96 in the prior quarter.
• Over five years, Price to Sales peaked at 32.53 in Q3 2024 and troughed at 3.4 in Q3 2022.
• A 5-year average of 15.41 and a median of 16.48 in 2026 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales plunged 41.61% in 2023 and soared 429.13% in 2024, its largest moves.
• Over 5 years, Price to Sales stood at 3.44 in 2022, then soared by 82.78% to 6.29 in 2023, then surged by 323.9% to 26.66 in 2024, then retreated by 22.05% to 20.78 in 2025, then retreated by 23.05% to 15.99 in 2026.
• The last three Price to Sales figures came in at 15.99 (Q2 2026), 16.96 (Q1 2026), and 20.78 (Q4 2025), per Business Quant data.